Trial intelligence / Profile preview

LBVH0101 vs Hiberix 4th Dose in Toddlers

NCT01251133Phase 3Completed

Sponsor
LG Chem
Start
Jul 2008
Primary completion
Mar 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of LBVH0101 in Haemophilus influenzae type b infection (Hib), sponsored by LG Chem. Started Jul 2008; status: completed.

02

Drugs

LBVH0101
03

Conditions

Haemophilus influenzae type b infection (Hib)

Beyond the preview

Go deeper on NCT01251133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01251133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call